Overview

Dysport in Hallux Abducto Valgus (HAV) Phase IIa

Status:
Completed
Trial end date:
2020-05-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of treatment with multiple doses of Dysport in adults suffering from clinically significant pain associated with HAV who have not undergone surgery for their condition.
Phase:
Phase 2
Details
Lead Sponsor:
Ipsen
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
Hemagglutinins
onabotulinumtoxinA